Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jan 31, 2023

Tuvik Beker, CEO of Pangea Biomed, is looking for more accurate biomarkers for oncology to determine better who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...


Jan 31, 2023

Tuvik Beker CEO of Pangea Biomed is looking for more accurate biomarkers for oncology to better determine who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...


Jan 30, 2023

Dr. Ira Spector is the CEO and Co-Founder of SFA Therapeutics, a clinical stage biopharmaceutical company leading the way as a fourth-generation microbiome company to treat inflammatory and autoimmune diseases. The first microbiome companies focused on fecal transplants, while the next innovation was probiotics. The...


Jan 30, 2023

Dr. Ira Spector is the CEO and Co-Founder of SFA Therapeutics, a clinical stage biopharmaceutical company leading the way as a fourth-generation microbiome company to treat inflammatory and autoimmune diseases. The first microbiome companies focused on fecal transplants, while the next innovation was probiotics. The...


Jan 27, 2023

Dr. Jula Inrig is the Chief Medical Officer of Travere Therapeutics and is eager to find innovative treatments for rare kidney diseases, which can be challenging to diagnose and have limited therapeutic options. In clinical trials, their lead candidate, sparsentan, reduces proteinuria significantly in patients with IgA...